Новости медицины портала Remedium.ru - самая актуальная информация о рынке лекарств и медицинского обеспечения

Опрос для врачей

  1. Пользуетесь ли вы интернетом на работе?

Вход на сайт

Авторизоваться
Логин:
Пароль:
Регистрация
Забыли свой пароль?

Facebook

Вакансии фармкомпанийВакансии

Все вакансии




Реклама


Главная / Врачам

12.02.2018

Может ли амтолметил гуацил пригодиться в хирургической практике?








Список литературы

1. Каратеев А.Е., Насонов Е.Л., Яхно Н.Н. и др. Клинические рекомендации «Рациональное применение нестероидных противовоспалительных препаратов (НПВП) в клинической практике». Современная ревматология, 2015, 1: 4-24.
2. Боль (практическое руководство для врачей). Под ред. Яхно Н.Н., Кукушкина М.Л., Москва, Издательство РАМН, 2012, 512 c.
3.  Allegri M, Clark MR, De Andrés J, Jensen TS. Acute and chronic pain: where we are and where we have to go. Minerva Anestesiol, 2012 Feb, 78(2): 222-35. Epub 2011 Nov 18.
4. Schug S, Manopas A. Update on the role of non-opioids for postoperative pain treatment. Best Pract Res Clin Anaesthesiol, 2007, 21(1): 15-30.
5. Camu F. The role of COX-2 inhibitors in pain modulation. Drug, 2003, 63(suppl.): 1-7.
6. Mehta V, Johnston A, Cheung R, Bello A, Langford R. Intravenous parecoxib rapidly leads to COX-2 inhibitory concentration of valdecoxib in the central nervous system. Clin Pharmacol Ther, 2008, 83(3): 430-435.
7. Dembo G, Park S, Kharasch E. Central nervous system concentrations of cyclooxygenase-2 inhibitors in humans. Anesthesiology, 2005, 102(2): 409-415.
8. Bianchi M, Martucci C, Ferrario P, Franchi S, Sacerdote P. Increased Tumor Necrosis Factor- and Prostaglandin E2 Concentrations in the Cerebrospinal Fluid of Rats with Inflammatory Hyperalgesia: The Effects of Analgesic Drugs. Anesth Analg, 2007, 104: 949-954.
9. Marret E, Kurdi O, Zufferey P, Bonnet F: Effects of nonsteroidal antiinflammatory drugs on patient-controlled analgesia morphine side effects. Anesthesiology, 2005, 102: 1249-60.
10. Elia N, Lysakowski C, Tramèr M. Does Multimodal Analgesia with Acetaminophen, Non-steroidal Antiinflammatory Drugs, or Selective Cyclooxygenase-2 Inhibitors and Patient-controlled Analgesia Morphine Offer Advantages over Morphine Alone?: Meta-analyses of Randomized Trials. Anesthesiology, 2005, 103(6): 1296-1304.
11. Lamplot J, Wagner E, Manning D. Multimodal Pain Management in Total Knee Arthroplasty: A Prospective Randomized Controlled Trial. J Arthroplasty, 2013 Jul 11. pii: S0883-5403(13)00418-X. doi: 10.1016/j.arth.2013.06.005. [Epub ahead of print].
12. White P, Raeder J, Kehlet H. Ketorolac: its role as part of a multimodal analgesic regimen. Anesth Analg, 2012, 114(2): 250-254.
13. Guidelines for the Management of Postoperative Pain after Total Knee Arthroplasty Korean Knee Society Korean Knee Society. Knee Surg Relat Res, 2012, 24(4): 201-207. http://dx.doi.org/10.5792/ksrr.2012.24.4.201.
14. Осипова Н.А., Петрова В.В., Ермолаев П.М., Береснев В.А. Нестероидные противовоспалительные препараты в лечении послеоперационной боли у онкологических больных. Фарматека, 2006, 6: 74-78.
15. Puig MM. Can we prevent acute pain becoming chronic? J Pain Palliat Care Pharmacother, 2013 Aug, 27(3): 284-5. doi: 10.3109/15360288.2013.817499. Epub 2013 Aug 2.
16. Werner MU, Kehlet H. Characterization of persistent postoperative pain by quantitative sensory testing. Eur J Pain Suppl, 2010, 4: 203-7.
17. Granot M. Can we predict persistent postoperative pain by testing preoperative experimental pain? Curr Opin Anaesthesiol, 2009, 22: 425-30.
18. Piscitelli P, Iolascon G, Innocenti M et al. Painful prosthesis: approaching the patient with persistent pain following total hip and knee arthroplasty. Clinical Cases in Mineral and Bone Metabolism, 2013, 10(2): 97-110.
19. Hofmann S, Seitlinger G, Djahani O, Pietsch M. The painful knee after TKA: a diagnostic algorithm for failure analysis. Knee Surg Sports Traumatol Arthrosc, 2011, 19(9): 1442-1452.
20. Seil R, Pape D. Causes of failure and etiology of painful primary total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc, 2011, 19(9): 1418-1432.
21. Wylde V, Hewlett S, Learmonth I, Dieppe P. Persistent pain after joint replacement: prevalence, sensory qualities, and postoperative determinants. Pain, 2011, 152(3): 566-572.
22. Liu SS, Buvanendran A, Rathmell JP et al. A cross-sectional survey on prevalence and risk factors for persistent postsurgical pain 1 year after total hip and knee replacement. Reg Anesth Pain Med, 2012 Jul-Aug, 37(4): 415-22. doi: 10.1097/AAP.0b013e318251b688.
23. Bourne R, Chesworth B, Davis A et al. Patient Satisfaction after Total Knee Arthroplasty. Who is Satisfied and Who is Not? Clin Orthop Relat Res, 2010, 468: 57-63.
24. Harirforoosh S, Asghar W, Jamali F. Adverse Effects of Nonsteroidal Antiinflammatory Drugs: An Update of Gastrointestinal, Cardiovascular and Renal Complications. J Pharm Pharm Sci, 2013, 16(5): 821-47.
25. Helin-Salmivaara A, Saarelainen S, Gronroos J, et al. Risk of upper gastrointestinal events with the use of various NSAIDs: A case-control study in a general population. Scan J Gastroenterol, 2007, 42: 923-932.
26. Krum H, Swergold G, Curtis SP, Kaur A, Wang H, Smugar SS, et al. Factors associated with blood pressure changes in patients receiving diclofenac or etoricoxib: results from the MEDAL study. J Hypertens, 2009, 27(4): 886-93.
27. Combe B, Swergold G, McLay J et al. Cardiovascular safety and gastrointestinal tolerability of etoricoxib vs diclofenac in a randomized controlled clinic trial (The MEDAL study). Rheumatology, 2009, 48: 425-432.
28. Varas-Lorenzo C, Riera-Guardia N, Calingaert B, Castellsague J, Salvo F, Nicotra F, Sturkenboom M, Perez-Gutthann S. Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies. Pharmacoepidemiology and Drug Safety, 2013, 22: 559-570. DOI: 10.1002/pds Published online 25 April 2013 in Wiley Online Library (wileyonlinelibrary.com).
29. Cordrey LJ. Tolmetin sodium, a new anti-arthritis drug: double-blind and long-term studies. Journal of the American Geriatrics Society, 1976, 24(10): 440-446.
30. AHFS Drug Information 2007. McEvoy GK, ed. Tolmetin. Bethesda, MD: American Society of Health-System Pharmacists; 2007: 2118-2122.
31. Garg A, Shoeb A, Moodahadu LS et al. Amtolmetin: A Reappraisal of NSAID with Gastroprotection. Arthritis, 2016, 2016: 7103705. doi: 10.1155/2016/7103705. Epub 2016 Mar 22.
32. Coruzzi G, Coppelli G, Spaggiari S et al. Gastroprotective effects of amtolmetin guacyl: a new non-steroidal anti-inflammatory drug that activates inducible gastric nitric oxide svnthase. Dig Liver Dis, 2002, 34(6): 403-10.
33. Tubaro E, Belogi L, Mezzadri CM. The mechanism of action of amtolmetin guacyl, a new gastroprotective nonsteroidal anti-inflammatory drug. European Journal of Pharmacology, 2000, 387: 233-244.
34. Morini G, Guaita E, Lazzaretti M., et al. Morphological features of rat gastric mucosa after acute and chronic treatment with amtolmetin guacyl: comparison with non-selective and COX-2-selective NSAIDs. Digestion, 2003, 68(2-3): 124-32.
35. Riezzo G, Chiloiro M, Montanaro S. Protective effect of amtolmetin guacyl versus placebo diclofenac and misoprostol in healthy volunteers evaluated as gastric electrical activity in alcohol-induced stomach damage. Dig Dis Sci, 2001, 46(8): 1797-804.
36. Biasi G, Marcolongo R. Efficacy and safety of amtolmetin guacyl in the treatment of acute osteoarthritis. Minerva Med, 2001 Oct, 92(5): 315-24.
37. Tavella A, Ursini G. A clinical study on the anti-inflammatory activity and gastrointestinal tolerability of amtolmetin guacyl, a new NSAID, compared with diclofenac in aged patients with osteoarticular diseases. Article in Italian. Clin Ter, 1997 Nov, 148(11): 543-8.
38. Marcolongo R, Frediani B, Biasi G et al. A Meta-Analysis of the Tolerability of Amtolmetin Guacil, a Novel, Effective Nonsteroidal Anti-Inflammatory Drug, Compared with Established Agents. Clin Drug Invest, 1999, 17(2): 89-96.
39. Jajić Z, Malaise M, Nekam K et al. Gastrointestinal safety of amtolmetin guacyl in comparison with celecoxib in patients with rheumatoid arthritis. Clin Exp Rheumatol, 2005, 23(6): 809-18. 40. Гайдукова И.З., Ребров А.П., Апаркина А.В., Хондкарян Э.В. Эффективность и кардиоваскулярная безопасность амтолметин гуацила (Найзилата) у больных анкилозирующим спондилитом: промежуточные результаты исследования КОРОНА. Эффективная фармакотерапия. Ревматология. Травматология. Ортопедия, 2015, 3-4: 47-53. 


Ключевые слова: боль, послеоперационное обезболивание, НПВП, амтолметил гуацил, НПВП-гастропатия, кардиова-скулярные осложнения
 

Последние статьи



Мероприятия

     2018
След. год

Пн Вт Ср Чт Пт Сб Вс
30 1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31 1 2 3


Подписка


Реклама


Мы в Twitter

Для смартфона

Читайте новости и статьи в своем смартфоне или планшете.